Lichtenstein Gary R, Sands Bruce E, Pazianas Michael
University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, Gastroenterology Division, Department of Medicine, Philadelphia, PA 19104-4283, USA.
Inflamm Bowel Dis. 2006 Aug;12(8):797-813. doi: 10.1097/00054725-200608000-00016.
The following are guidelines for evaluation and consideration for treatment of patients with inflammatory bone disease (IBD) after bone mineral density (BMD) measurements. The Crohn's & Colitis Foundation of America (CCFA) has indicated that its recommendations are intended to serve as reference points for clinical decision-making, not as rigid standards, limits, or rules. They should not be interpreted as quality standards.
以下是骨密度（BMD）测量后炎性骨病（IBD）患者评估及治疗考量的指南。美国克罗恩病和结肠炎基金会（CCFA）指出，其建议旨在作为临床决策的参考点，而非严格的标准、限制或规则。它们不应被解读为质量标准。
Zotero 插件